Monoclonal Antibodies Stocks List Ranked for 2024

Symbol	Grade	Name	% Change
TGTX	B	TG Therapeutics, Inc.	2.69
CDMO	B	Avid Bioservices, Inc.	11.48
ZYME	B	Zymeworks Inc.	7.43
MRUS	B	Merus N.V.	2.58
XNCR	C	Xencor, Inc.	2.20
APGE	C	Apogee Therapeutics, Inc.	-1.29
XOMA	C	XOMA Corporation	-6.96
BCAB	C	BioAtla, Inc.	5.10
SLRN	C	Acelyrin Inc.	-0.83
HALO	C	Halozyme Therapeutics, Inc.	-1.62

Symbol	Grade	Name	Weight
PBE	B	PowerShares Dynamic Biotech & Genome	8.76
BBP	A	BioShares Biotechnology Products Fund	4.02
XBI	A	SPDR S&P Biotech ETF	3.31
FBT	A	First Trust Amex Biotech Index Fund	3.2
SBIO	A	ALPS Medical Breakthroughs ETF	3.2

Compare ETFs

Compare PBE to FBT Compare XBI to FBT Compare XBI to SBIO

Date	Stock	Title
Nov 7	CDMO	Avid Bioservices to be acquired for $1.1B in cash by GHO, Ampersand
Nov 7	XOMA	XOMA GAAP EPS of -$1.59, revenue of $7.2M
Nov 7	XOMA	XOMA Royalty: Q3 Earnings Snapshot
Nov 7	XOMA	XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities
Nov 7	TGTX	TG Therapeutics, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
Nov 7	CDMO	GHO and Ampersand Capital to acquire Avid Bioservices
Nov 7	XNCR	Xencor GAAP EPS of -$0.71 beats by $0.30, revenue of $10.71M misses by $2.62M
Nov 7	CDMO	Hershey, Upwork And 3 Stocks To Watch Heading Into Thursday
Nov 6	CDMO	Avid Bioservices to Go Private in $1.1 Billion Deal
Nov 6	CDMO	Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction
Nov 6	XNCR	Xencor (XNCR) Reports Q3 Loss, Tops Revenue Estimates
Nov 6	XNCR	Xencor: Q3 Earnings Snapshot
Nov 6	XNCR	Xencor Reports Third Quarter 2024 Financial Results
Nov 6	MRUS	Merus to Present at Upcoming Investor Conferences
Nov 6	SLRN	ACELYRIN, INC. to Report Third Quarter 2024 Financial Results and Corporate Update on November 13, 2024
Nov 5	HALO	Looking Into Halozyme Therapeutics's Recent Short Interest
Nov 5	TGTX	TG Therapeutics: Modest Q3 Sales Beat, Focus Shifts To Early 2025 Updates
Nov 5	MRUS	Merus: Petosemtamab Set Up For December 2024 Data Presentation
Nov 5	HALO	Halozyme: Looking For More Growth Following Record Q3 Earnings
Nov 5	MRUS	Merus says FDA extended review period for cancer drug

Monoclonal Antibodies: Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.